VANGUARD GROUP INC – Vertex Pharmaceuticals Incorporated Transaction History
VANGUARD GROUP INC portfolio value:
$6.11B
portfolio value
VANGUARD GROUP INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.41% | 293.86K shares | 246.58M | $289.54 | 21.13M |
| Q2 2022 | share | Increase | +1.78% | 365.00K shares | 529.11M | $281.79 | 20.83M |
| Q1 2022 | share | Increase | +1.58% | 317.62K shares | 916.73M | $260.97 | 20.47M |
| Q4 2021 | share | Decrease | -1.40% | -286.84K shares | 718.12M | $222.45 | 20.15M |
| Q3 2021 | share | Increase | +0.96% | 193.47K shares | -374.74M | $181.39 | 20.44M |
| Q2 2021 | share | Decrease | -0.82% | -166.49K shares | -304.28M | $201.63 | 20.24M |
| Q1 2021 | share | Decrease | -0.08% | -17.33K shares | -442.01M | $214.89 | 20.41M |
| Q4 2020 | share | Decrease | -1.24% | -256.86K shares | -800.99M | $236.34 | 20.43M |
| Q1 2016 | share | Increase | +2.98% | 432.36K shares | -637.72M | $79.49 | 14.93M |